Literature DB >> 15861137

Association of Csk to VE-cadherin and inhibition of cell proliferation.

Ulf Baumeister1, Ruth Funke, Klaus Ebnet, Henrik Vorschmitt, Stefan Koch, Dietmar Vestweber.   

Abstract

Vascular endothelial cadherin (VE-cadherin) mediates contact inhibition of cell growth in quiescent endothelial cell layers. Searching for proteins that could be involved in VE-cadherin signaling, we found the cytosolic C-terminal Src kinase (Csk), a negative regulator of Src family kinases. We show that Csk binds via its SH2 domain to the phosphorylated tyrosine 685 of VE-cadherin. VE-cadherin recruits Csk to cell contacts and both proteins can be co-precipitated from cell lysates of transfected cells and endothelial cells. Association of VE-cadherin and Csk in endothelial cells increased with increasing cell density. CHO cells expressing the tyrosine replacement mutant VE-cadherin-Y685F grow to higher cell densities than cells expressing wild-type VE-cadherin. Overexpression of Csk in these cells under an inducible promoter inhibits cell proliferation in the presence and absence of VE-cadherin, but not in the presence of VE-cadherin-Y685F. Reduction of Csk expression by RNA interference enhances endothelial cell proliferation. Our results suggest that the phosphorylated tyrosine residue 685 of VE-cadherin and probably the binding of Csk to this site are involved in inhibition of cell growth triggered by cell density.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15861137      PMCID: PMC1142580          DOI: 10.1038/sj.emboj.7600647

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

1.  Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells.

Authors:  R Abu-Ghazaleh; J Kabir; H Jia; M Lobo; I Zachary
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

Review 2.  Src in cancer: deregulation and consequences for cell behaviour.

Authors:  Margaret C Frame
Journal:  Biochim Biophys Acta       Date:  2002-06-21

3.  VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts.

Authors:  Roman Nawroth; Gregor Poell; Alexander Ranft; Stephan Kloep; Ulrike Samulowitz; Gregor Fachinger; Matthew Golding; David T Shima; Urban Deutsch; Dietmar Vestweber
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

Review 4.  Caught up in a Wnt storm: Wnt signaling in cancer.

Authors:  Rachel H Giles; Johan H van Es; Hans Clevers
Journal:  Biochim Biophys Acta       Date:  2003-06-05

5.  Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.

Authors:  Ming-Tsan Lin; Men-Luh Yen; Chia-Yi Lin; Min-Liang Kuo
Journal:  Mol Pharmacol       Date:  2003-11       Impact factor: 4.436

6.  Dual roles of the C-terminal Src kinase (Csk) during developmental vascularization.

Authors:  Li-Juan Duan; Akira Imamoto; Guo-Hua Fong
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

Review 7.  VEGF-receptor signal transduction.

Authors:  Michael J Cross; Johan Dixelius; Taro Matsumoto; Lena Claesson-Welsh
Journal:  Trends Biochem Sci       Date:  2003-09       Impact factor: 13.807

8.  Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction.

Authors:  Sara Weis; Satoshi Shintani; Alberto Weber; Rudolf Kirchmair; Malcolm Wood; Adrianna Cravens; Heather McSharry; Atsushi Iwakura; Young-Sup Yoon; Nathan Himes; Deborah Burstein; John Doukas; Richard Soll; Douglas Losordo; David Cheresh
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

9.  Vascular endothelial growth factor induces SHC association with vascular endothelial cadherin: a potential feedback mechanism to control vascular endothelial growth factor receptor-2 signaling.

Authors:  Adriana Zanetti; Maria Grazia Lampugnani; Giovanna Balconi; Ferruccio Breviario; Monica Corada; Luisa Lanfrancone; Elisabetta Dejana
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-04-01       Impact factor: 8.311

10.  Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.

Authors:  Maria Grazia Lampugnani; Adriana Zanetti; Monica Corada; Takamune Takahashi; Giovanna Balconi; Ferruccio Breviario; Fabrizio Orsenigo; Anna Cattelino; Rolf Kemler; Thomas O Daniel; Elisabetta Dejana
Journal:  J Cell Biol       Date:  2003-05-26       Impact factor: 10.539

View more
  60 in total

1.  VE-cadherin phosphorylation decides: vascular permeability or diapedesis.

Authors:  Adama Sidibé; Beat A Imhof
Journal:  Nat Immunol       Date:  2014-03       Impact factor: 25.606

Review 2.  Reactive oxygen species in inflammation and tissue injury.

Authors:  Manish Mittal; Mohammad Rizwan Siddiqui; Khiem Tran; Sekhar P Reddy; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2013-10-22       Impact factor: 8.401

3.  Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation.

Authors:  Kunihiko Hatanaka; Michael Simons; Masahiro Murakami
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-29       Impact factor: 4.733

4.  TIMP-2 upregulates RECK expression via dephosphorylation of paxillin tyrosine residues 31 and 118.

Authors:  J Oh; T Diaz; B Wei; H Chang; M Noda; W G Stetler-Stevenson
Journal:  Oncogene       Date:  2006-02-20       Impact factor: 9.867

5.  Dynamic phosphorylation of VE-cadherin Y685 throughout mouse estrous cycle in ovary and uterus.

Authors:  Adama Sidibé; Helena Polena; Jeremy Razanajatovo; Tiphaine Mannic; Nicolas Chaumontel; Soumalamaya Bama; Irène Maréchal; Philippe Huber; Danielle Gulino-Debrac; Laurence Bouillet; Isabelle Vilgrain
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-23       Impact factor: 4.733

6.  The FGF system has a key role in regulating vascular integrity.

Authors:  Masahiro Murakami; Loc T Nguyen; Zhen W Zhuang; Zhen W Zhang; Karen L Moodie; Peter Carmeliet; Radu V Stan; Michael Simons
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

Review 7.  ROS-activated calcium signaling mechanisms regulating endothelial barrier function.

Authors:  Anke Di; Dolly Mehta; Asrar B Malik
Journal:  Cell Calcium       Date:  2016-02-17       Impact factor: 6.817

Review 8.  Tissue organization by cadherin adhesion molecules: dynamic molecular and cellular mechanisms of morphogenetic regulation.

Authors:  Carien M Niessen; Deborah Leckband; Alpha S Yap
Journal:  Physiol Rev       Date:  2011-04       Impact factor: 37.312

Review 9.  Cellular and molecular regulation of vascular permeability.

Authors:  Lauren M Goddard; M Luisa Iruela-Arispe
Journal:  Thromb Haemost       Date:  2013-02-07       Impact factor: 5.249

10.  VE-PTP controls blood vessel development by balancing Tie-2 activity.

Authors:  Mark Winderlich; Linda Keller; Giuseppe Cagna; Andre Broermann; Olena Kamenyeva; Friedemann Kiefer; Urban Deutsch; Astrid F Nottebaum; Dietmar Vestweber
Journal:  J Cell Biol       Date:  2009-05-18       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.